# OnCo record paper-groot-kras-ctdna-clinical-test-resected-pancreatic-ccr-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-groot-kras-ctdna-clinical-test-resected-pancreatic-ccr-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-groot-kras-ctdna-clinical-test-resected-pancreatic-ccr-2019" ;
  schema:name "Circulating tumor DNA as a clinical test in resected pancreatic cancer"@en ;
  schema:description "A clinically accredited blood test for the four common KRAS mutations found tumour DNA in half of 59 patients before surgery and predicted recurrence afterwards with 90% sensitivity, about three months before the scan."@en ;
  schema:url <https://onco.cc/key-papers/paper-groot-kras-ctdna-clinical-test-resected-pancreatic-ccr-2019/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-19-0197>, <https://pubmed.ncbi.nlm.nih.gov/31142500/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-19-0197> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Groot VP, Mosier S, Javed AA, et al." ;
  onco:related <https://onco.cc/biomarkers/ctdna-mrd-positive/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .